VANCOUVER, BC / ACCESSWIRE / October 15, 2020 / NeutriSci International Inc. ('NeutriSci' or the 'Company') (TSXV:NU)(OTCQB:NRXCF)(FRANKFURT:1N9), an innovative technology company developing products for the nutraceutical industry, is very pleased to announce that Cryopharm Corp. ('Cryopharm'), its US manufacturing and distribution partner, will begin the distribution of NeutriSci's and Cryopharm's CBD & THC products into the state of Washington.
After successfully launching in California, the entire Cryopharm product line powered by NeutriSci's ingredients and technology, will be introduced into 400 plus dispensaries across the state of Washington starting in December 2020; consisting of Marbl Melts™, Kali Juice™ as well as NeutriSci's Kushtabs™ and Zenstix™.
NeutriSci's Zenstix™ and Kushtabs™ quick melting tabs provide a powerful maximum allowable dosage per serving of 10mg. Every stick contains 6 tablets in a child-resistant package. These calorie and sugar-free products come in three flavors (Lemon Lime, Iced Pomegranate and Raspberry Lemonade).
Cryopharm's Marbl Melts™ represent an industry-first cannabis infused product; flavorful, micro dosed, rapidly dissolvable oral melts infused with THC & CBD. NeutriSci's core ingredients form the basis of Marbl Melts™, containing a clinically tested dosage providing on-set in as little as 12 minutes; compared to traditional cannabinoid infusion methods that often have incorrect dosages that can potentially take up to 120 minutes to become active. Marbl Melts™ are available in several unique offerings designed for specific uses such as sleep, energy, relaxation.
For the health-conscious social butterfly, Kali Juice™ is a delicious cannabis-infused drink mix with zero sugar and zero calories and comes in three different flavours to match the experience of a beachside mixer, a club hot spot, to a secret after hours party.
Washington is a Pacific state bordered by Canada to the north, the Pacific Ocean to the west, Oregon to the south, and Idaho to the east. It is the third most densely populated state in the western United States, after California and Hawaii. The state's population comprises of 7.6 million people and is growing at a rate that is greater than the national average. Seattle is the largest city in both the state of Washington with a population of 3.98 million, making it the 15th-largest in the United States.
Anyone 21+ in Washington state is allowed to buy recreational marijuana and possess up to 1oz of marijuana, 7g of concentrates, 16oz of edibles or 72oz of liquid cannabis product. Washington state has seen gross sales of cannabis products grow exponentially over the past 5 years; starting in 2014 with sales of $31 million exploding to over a billion in 2019.
Glen Rehman, CEO of NeutriSci, stated: 'Washington state represents the second highest grossing recreational cannabis market in the world with annual sales exceeding $1 billion USD. This agreement offers NeutriSci and our partners an amazing opportunity to expand our network and our brands foothold in the American marketplace. Having the ability to secure distribution and sales in Washington State will also open the doors for further expansion to other states like Nevada, Oklahoma and Michigan. We look forward to expanding the brands into as many states as we can in the coming months.'
About NeutriSci International Inc.
NeutriSci specializes in the innovation, production, and formulation of nutraceutical products. Established in 2009, NeutriSci's is building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy®, the Company's natural energy and focus supplement that has at its core, the beneficial effects of blueberries. For more information, please visit: www.neutrisci.com.
On Behalf of the Board of Directors of
NEUTRISCI INTERNATIONAL INC.
Tel: (403) 264-6320
For investor inquiries, please contact email@example.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward-looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure, or prevent any disease.
SOURCE: NeutriSci International Inc
View source version on accesswire.com: